Money and Research

Regarding your FrontLines item, "The money-making academy,"1 at first I wondered if it was an April fool's joke, then I realized it was serious. This is an unsupported perpetuation of a myth promulgated by the research university establishment. What evidence is there that the commercial activities of universities have benefited society as a whole? Falling tuition costs? Cheaper drug prices? Reduced university budgets supported by fewer taxpayer dollars? I would argue that, in fact, all of the e

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

I would argue that, in fact, all of the evidence clearly demonstrates the opposite effect. The increasing commercialization of university research activities has increased the cost to society as a whole. Universities are pressured to compete for top-dollar researchers, and to maintain state-of-the-art research facilities. The university license agreements generate royalties that are funneled back into the research activities. Companies paying royalties on such licenses merely pass on the cost to the consumer/taxpayer by way of higher drug prices. And during this entire process, both universities and companies can plead innocent as to the spiraling costs of research.

It is a sham, designed to perpetuate the inflated costs of research and the huge support/regulatory system in place to encourage it. If universities truly wanted to benefit society by their research discoveries, they would dedicate their discoveries, sponsored by the public funds, to the public for all to use equally, and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Mark Chao

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo